[Management of cervico-vaginal dystrophies].
Fifty-nine outpatients affected by cervico-vaginal dystrophy with manifest symptoms were included in the study. Following initial tests (colposcopy with Schiller's test, colpocytological test, analysis of symptoms), a cycle of treatment was commenced using the insertion of a vaginal pessary of Polydeoxy-ribonucleotide (PDRN) in the evening for 20 days. A control on day 28 revealed a marked improvement of the symptoms together with a positive evolution of objective tests. During the 10th week after the end of therapy, both subjective and objective findings tended to confirm the relapse towards pre-treatment conditions.
Zagami
L
L
Ospedale Maggiore, S. Giovanni Battista di Torino.
Lesca
F
F
D000287:Administration, Topical; D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D010570:Pessaries; D011089:Polydeoxyribonucleotides / Q000008:administration & dosage; D012008:Recurrence; D002577:Uterine Cervical Diseases / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D014623:Vaginal Diseases / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D014626:Vaginal Smears
D011089:Polydeoxyribonucleotides
Contributo allo studio della terapia delle distrofie cervico-vaginali.